392 related articles for article (PubMed ID: 26551033)
1. Cross-dressing: an alternative mechanism for antigen presentation.
Campana S; De Pasquale C; Carrega P; Ferlazzo G; Bonaccorsi I
Immunol Lett; 2015 Dec; 168(2):349-54. PubMed ID: 26551033
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
Dolan BP; Gibbs KD; Ostrand-Rosenberg S
J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
[TBL] [Abstract][Full Text] [Related]
3. Cross-dressing by donor dendritic cells after allogeneic bone marrow transplantation contributes to formation of the immunological synapse and maximizes responses to indirectly presented antigen.
Markey KA; Koyama M; Gartlan KH; Leveque L; Kuns RD; Lineburg KE; Teal BE; MacDonald KP; Hill GR
J Immunol; 2014 Jun; 192(11):5426-33. PubMed ID: 24790149
[TBL] [Abstract][Full Text] [Related]
4. Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection.
Wakim LM; Bevan MJ
Nature; 2011 Mar; 471(7340):629-32. PubMed ID: 21455179
[TBL] [Abstract][Full Text] [Related]
5. Differential use of autophagy by primary dendritic cells specialized in cross-presentation.
Mintern JD; Macri C; Chin WJ; Panozza SE; Segura E; Patterson NL; Zeller P; Bourges D; Bedoui S; McMillan PJ; Idris A; Nowell CJ; Brown A; Radford KJ; Johnston AP; Villadangos JA
Autophagy; 2015; 11(6):906-17. PubMed ID: 25950899
[TBL] [Abstract][Full Text] [Related]
6. Shaping of T Cell Functions by Trogocytosis.
Nakayama M; Hori A; Toyoura S; Yamaguchi SI
Cells; 2021 May; 10(5):. PubMed ID: 34068819
[TBL] [Abstract][Full Text] [Related]
7. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles.
Shen H; Ackerman AL; Cody V; Giodini A; Hinson ER; Cresswell P; Edelson RL; Saltzman WM; Hanlon DJ
Immunology; 2006 Jan; 117(1):78-88. PubMed ID: 16423043
[TBL] [Abstract][Full Text] [Related]
8. Bioorthogonal deprotection on the dendritic cell surface for chemical control of antigen cross-presentation.
Pawlak JB; Gential GP; Ruckwardt TJ; Bremmers JS; Meeuwenoord NJ; Ossendorp FA; Overkleeft HS; Filippov DV; van Kasteren SI
Angew Chem Int Ed Engl; 2015 May; 54(19):5628-31. PubMed ID: 25784151
[TBL] [Abstract][Full Text] [Related]
9. Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles.
Keller SA; von Allmen CE; Hinton HJ; Bauer M; Muntwiler S; Dietmeier K; Saudan P; Bachmann MF
J Immunol; 2009 May; 182(10):6261-6. PubMed ID: 19414779
[TBL] [Abstract][Full Text] [Related]
10. Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells.
Montealegre S; van Endert PM
Front Immunol; 2018; 9():3098. PubMed ID: 30666258
[TBL] [Abstract][Full Text] [Related]
11. A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells.
Segura E; Villadangos JA
Traffic; 2011 Dec; 12(12):1677-85. PubMed ID: 21777358
[TBL] [Abstract][Full Text] [Related]
12. Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity.
van Montfoort N; Camps MG; Khan S; Filippov DV; Weterings JJ; Griffith JM; Geuze HJ; van Hall T; Verbeek JS; Melief CJ; Ossendorp F
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6730-5. PubMed ID: 19346487
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of MHC class I-restricted antigen processing and cross-presentation.
Cresswell P; Ackerman AL; Giodini A; Peaper DR; Wearsch PA
Immunol Rev; 2005 Oct; 207():145-57. PubMed ID: 16181333
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells.
Dolan BP; Gibbs KD; Ostrand-Rosenberg S
J Immunol; 2006 Nov; 177(9):6018-24. PubMed ID: 17056526
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicle-mediated MHC cross-dressing in immune homeostasis, transplantation, infectious diseases, and cancer.
Zeng F; Morelli AE
Semin Immunopathol; 2018 Sep; 40(5):477-490. PubMed ID: 29594331
[TBL] [Abstract][Full Text] [Related]
16. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
[TBL] [Abstract][Full Text] [Related]
17. The ongoing saga of the mechanism(s) of MHC class I-restricted cross-presentation.
Grotzke JE; Sengupta D; Lu Q; Cresswell P
Curr Opin Immunol; 2017 Jun; 46():89-96. PubMed ID: 28528219
[TBL] [Abstract][Full Text] [Related]
18. Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications.
Wilson NS; Villadangos JA
Adv Immunol; 2005; 86():241-305. PubMed ID: 15705424
[TBL] [Abstract][Full Text] [Related]
19. Antibody-mediated targeting of antigen to C-type lectin-like receptors Clec9A and Clec12A elicits different vaccination outcomes.
Macri C; Dumont C; Panozza S; Lahoud MH; Caminschi I; Villadangos JA; Johnston AP; Mintern JD
Mol Immunol; 2017 Jan; 81():143-150. PubMed ID: 27978488
[TBL] [Abstract][Full Text] [Related]
20. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; GarcĂa-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]